ARCHIVES

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014